Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Austin, United States, March 24, 2026 (GLOBE NEWSWIRE) -- Virus Filtration Market Size & Growth Analysis: According to SNS Insider, The Virus Filtration Market size was valued at USD 5.71...
-
DALIAN, China, March 24, 2026 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy...
-
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global...
-
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the...
-
MONTRÉAL, 24 mars 2026 (GLOBE NEWSWIRE) -- NanoXplore Inc. (« NanoXplore » ou la « Société ») (TSX : GRA et OTCQX : NNXPF), chef de file mondial dans le domaine du graphène, est heureuse...
-
MONTREAL, Quebec, March 24, 2026 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, is pleased to announce the publication of its first...
-
~ Delivered Record Annual Revenue with Full-Year Net PEDMARK® Product Sales of $44.6 Million, Representing 50% Year-Over-Year Growth, and Q4 2025 Net Product Sales of $13.8 Million, Representing 75%...
-
HANGZHOU, China, March 24, 2026 (GLOBE NEWSWIRE) -- UTStarcom (the Company) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results for...
-
Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
-
Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms...